Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Introduction to Innate and Adaptive Immunity

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...

Urinary Tract Infection II: Pathophysiology

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...

Defense Mechanism Against Infection

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...

Urinary Tract Infection I: Introduction

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...

Microbiota of the Urogenital Tract

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...

Humoral Immune Responses

Humoral Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of donor cell type on nuclear remodelling in rabbit somatic cell nuclear transfer embryos.

Reproduction in domestic animals = Zuchthygiene·2011

Same author

The National Ballistics Imaging Comparison (NBIC) project.

Forensic science international·2011

Same author

Curcumin suppresses Streptococcus mutans adherence to human tooth surfaces and extracellular matrix proteins.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011

Same author

Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA delivery.

Gene therapy·2011

Same author

Examining brain-cognition effects of ginkgo biloba extract: brain activation in the left temporal and left prefrontal cortex in an object working memory task.

Evidence-based complementary and alternative medicine : eCAM·2011

Same author

Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus.

The British journal of dermatology·2011

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

Published on: December 1, 2017

Innate and adaptive immune responses in the urinary tract.

J Song¹, S N Abraham

¹Department of Molecular Genetics and Microbiology, Duke University Medical Centre, Durham, NC 27710, USA. jeongmin.song@duke.edu

European Journal of Clinical Investigation

|October 2, 2008

Summary

Emerging research reveals the urinary tract’s immune system, including Toll-like receptor 4 (TLR4) responses, combats Gram-negative pathogens. Modulating these immune responses may offer new treatments for urinary tract infections (UTIs) as antibiotic resistance grows.

More Related Videos

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Published on: October 18, 2019

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Related Experiment Videos

Last Updated: Jun 29, 2026

Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

Published on: December 1, 2017

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Published on: October 18, 2019

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Area of Science:

Immunology
Microbiology
Urology

Background:

Uropathogens initiate and persist in the urinary tract, necessitating understanding of host defense mechanisms.
The urinary tract possesses a complex immune system involving both innate and adaptive responses.
Gram-negative pathogens are common causes of urinary tract infections (UTIs).

Purpose of the Study:

To review recent findings on the immune system's role in combating urinary tract infections (UTIs).
To explore the potential of immunomodulation as a therapeutic strategy for UTIs.

Main Methods:

Review of recent scientific literature on urinary tract infections and host immunity.
Analysis of studies investigating Toll-like receptor 4 (TLR4) mediated innate immunity.
Evaluation of research on adaptive immune responses and vaccine development for UTIs.

Main Results:

A multifaceted innate immune response, involving Toll-like receptor 4 (TLR4), is activated by Gram-negative pathogens on bladder epithelial cells.
Adaptive immune responses in the urinary tract are effective, with vaccines showing protective immunity in animal and human studies.
Antibiotic resistance is increasing, highlighting the need for alternative therapeutic approaches.

Conclusions:

Modulating the innate and adaptive immune systems in the urinary tract presents a promising avenue for combating UTIs.
Toll-like receptor 4 (TLR4) ligands and other immunomodulators could become viable options for UTI treatment.
Further research into immune system modulation is crucial for developing novel UTI therapies.